Menu
GWAS Study

Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy.

Wu X, Ye Y, Rosell R et al.

21483023 PubMed ID
GWAS Study Type
1062 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

WX
Wu X
YY
Ye Y
RR
Rosell R
AC
Amos CI
SD
Stewart DJ
HM
Hildebrandt MA
RJ
Roth JA
MJ
Minna JD
GJ
Gu J
LJ
Lin J
BS
Buch SC
NT
Nukui T
RS
Ramirez Serrano JL
TM
Taron M
CA
Cassidy A
LC
Lu C
CJ
Chang JY
LS
Lippman SM
HW
Hong WK
SM
Spitz MR
RM
Romkes M
YP
Yang P
Chapter II

Abstract

Summary of the research findings

Interindividual variation in genetic background may influence the response to chemotherapy and overall survival for patients with advanced-stage non-small cell lung cancer (NSCLC).

327 European ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

1062
Total Participants
GWAS
Study Type
Yes
Replicated
735 European ancestry individuals
Replication Participants
European
Ancestry
Spain, U.S.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.